Literature DB >> 10971410

The 4G/4G genotype at nucleotide position -675 in the promotor region of the plasminogen activator inhibitor 1 (PAI-1) gene is less frequent in young patients with minor stroke than in controls.

G Endler1, W Lalouschek, M Exner, G Mitterbauer, D Häring, C Mannhalter.   

Abstract

Genetic risk factors play an important role in the aetiology of vascular diseases. The insertion/deletion polymorphism (4G/5G) in the promotor region of the plasminogen activator inhibitor 1 (PAI-1) gene has been associated with an increased risk of myocardial infarction. We investigated 136 patients with minor stroke (MS) and transient ischaemic attack (TIA) and found a prevalence of 0.32 for the 4G/4G genotype in patients compared with 0.42 in 115 age-matched healthy controls. The 4G/4G genotype was significantly less frequent among 61 patients symptomatic before the age of 60 years (prevalence 0.20) than in 75 patients symptomatic after 60 years of age (prevalence 0.42; odds ratio). Our results indicate that the 4G/4G genotype is not a risk factor for MS or TIA and may even be protective in young patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971410     DOI: 10.1046/j.1365-2141.2000.02164.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and PAI-1 plasma levels in young patients with ischemic stroke.

Authors:  Adriano de Paula Sabino; Daniel Dias Ribeiro; Caroline Pereira Domingueti; Mariana Silva Dos Santos; Telma Gadelha; Luci Maria Santana Dusse; Maria das Graças Carvalho; Ana Paula Fernandes
Journal:  Mol Biol Rep       Date:  2011-03-04       Impact factor: 2.316

2.  Plasminogen Activator Inhibitor-1 (PAI-1) gene 4G/5G alleles frequency distribution in the Lebanese population.

Authors:  Dina M R Shammaa; Amira S Sabbagh; Ali T Taher; Ghazi S Zaatari; Rami A R Mahfouz
Journal:  Mol Biol Rep       Date:  2007-06-20       Impact factor: 2.316

Review 3.  Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.

Authors:  Xin Hu; Xin Zan; Zhiyi Xie; Yunke Li; Sen Lin; Hao Li; Chao You
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

Review 4.  Blood Biomarkers in Minor Stroke and Transient Ischemic Attack.

Authors:  Jiejie Li; Yongjun Wang
Journal:  Neurosci Bull       Date:  2016-06-01       Impact factor: 5.203

5.  Vascular Genetic Variants and Ischemic Stroke Susceptibility in Albanians from the Republic of Macedonia.

Authors:  Bajram Kamberi; Farije Kamberi; Mirko Spiroski
Journal:  Open Access Maced J Med Sci       Date:  2016-10-01

6.  Lack of Associations Between PAI-1 and FXIII Polymorphisms and Arterial Ischemic Stroke in Children: A Systematic Review and Meta-Analysis.

Authors:  Beata Sarecka-Hujar; Ilona Kopyta; Michał Skrzypek
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

7.  The association between gene polymorphisms and leukocytosis with thrombotic complications in patients with essential thrombocythemia and polycythemia vera.

Authors:  Ozgür Mehtap; Elif Birtaş Ateşoğlu; Pınar Tarkun; Emel Gönüllü; Hakan Keski; Yıldıray Topçu; Nilüfer Uzülmez; Deniz Sünnetçi; Abdullah Hacıhanefioğlu
Journal:  Turk J Haematol       Date:  2012-06-15       Impact factor: 1.831

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.